Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration

详细信息	查看全文 | 推荐本文 |

• 作者：Rory D. Spence ^{rory.spence@ucla.edu} ; Rhonda R. Voskuhl ; ^{rvoskuhl@ucla.edu}
• 关键词：EAE ; MS ; ER伪 ; ER尾 ; Estriol ; Estradiol ; Testosterone ; 5伪DHT ; Neuroprotection
• 刊名：Frontiers in Neuroendocrinology
• 出版年：2012
• 期刊代码：79_00913022
• 类别：neu
• 出版时间：January, 2012
• 卷：33
• 期：1
• 页码：105-115
• 文件大小：462 K

摘要

Multiple sclerosis (MS) is a disease characterized by inflammation and demyelination. Currently, the cause of MS is unknown. Experimental autoimmune encephalomyelitis (EAE) is the most common mouse model of MS. Treatments with the sex hormones, estrogens and androgens, are capable of offering disease protection during EAE and are currently being used in clinical trials of MS. Beyond endogenous estrogens and androgens, treatments with selective estrogen receptor modulators (SERMs) for estrogen receptor alpha (ER伪) and estrogen receptor beta (ER尾) are also capable of providing disease protection. This protection includes, but is not limited to, prevention of clinical disease, reduction of CNS inflammation, protection against demyelination, and protection against axonal loss. In EAE, current efforts are focused on using conditional cell specific knockouts of sex hormone receptors to identify the in vivo targets of these estrogens and androgens as well as downstream molecules responsible for disease protection.